1. Home
  2. NNN vs TXG Comparison

NNN vs TXG Comparison

Compare NNN & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NNN REIT Inc.

NNN

NNN REIT Inc.

N/A

Current Price

$41.31

Market Cap

7.9B

Sector

Real Estate

ML Signal

N/A

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

N/A

Current Price

$62.85

Market Cap

9.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NNN
TXG
Founded
1984
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
9.3B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
NNN
TXG
Price
$41.31
$62.85
Analyst Decision
Hold
Buy
Analyst Count
18
17
Target Price
$45.03
★ $68.14
AVG Volume (30 Days)
2.8M
★ 3.3M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 5.94%
N/A
EPS Growth
N/A
★ 76.97
EPS
★ 1.58
N/A
Revenue
★ $926,213,000.00
$245,893,000.00
Revenue This Year
$6.19
N/A
Revenue Next Year
$5.33
$11.72
P/E Ratio
$26.41
★ N/A
Revenue Growth
6.55
★ 68.06
52 Week Low
$38.90
$15.12
52 Week High
$50.00
$102.81

Technical Indicators

Market Signals
Indicator
NNN
TXG
Relative Strength Index (RSI) 47.61 43.00
Support Level $40.50 $56.98
Resistance Level $45.52 $63.82
Average True Range (ATR) 0.76 6.21
MACD 0.07 -1.04
Stochastic Oscillator 40.20 22.71

Price Performance

Historical Comparison
NNN
TXG

About NNN NNN REIT Inc.

NNN REIT Inc is a real estate investment trust that acquires, owns, invests in, and develops high-quality properties mainly leased under long-term net leases with minimal capital expenditure requirements. The company focuses mainly on retail properties, with a portfolio including convenience stores, automotive service properties, restaurants, theatres, entertainment venues, dealerships, and other retail-related assets. Primary business objectives emphasize retail properties, and it may invest in a wide variety of property and tenant types, leases, mortgages, loans secured by personal property, loans secured by partnership or membership interests, and securities of other REITs or other issuers.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: